TGS and SLB Announce Engagement III in the U.S. Gulf of Mexico
OSLO, Norway (28 February 2023) – TGS, a global provider of energy data and intelligence, in collaboration with SLB, today announced the Engagement III ultra-long offset ocean-bottom node (OBN) acquisition in Green Canyon, U.S. Gulf of Mexico.
The 111 OCS block survey is underway, and acquisition is expected to be complete in April 2023. Following the success of previous projects, imaging uplifts will be delivered through the application of full-waveform inversion (FWI) velocity model building utilizing the ultra-long offsets—imaging to be carried out by SLB with final results expected in mid-2024. Engagement III is the fifth multi-client ultra-long offset OBN acquisition in the Gulf of Mexico and extends the data coverage south from prior phases.
Kristian Johansen, CEO at TGS, commented: “TGS and SLB continue to lead the advancements of ultra-long offset OBN acquisition in the U.S. Gulf of Mexico, providing the industry with access to marked improvements in image quality in this geologically complex basin.”
The project is supported by industry funding.
TGS provides scientific data and intelligence to companies active in the energy sector. In addition to a global, extensive and diverse energy data library, TGS offers specialized services such as advanced processing and analytics alongside cloud-based data applications and solutions.
Forward Looking Statement
All statements in this press release other than statements of historical fact are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that are difficult to predict and are based upon assumptions as to future events that may not prove accurate. These factors include volatile market conditions, investment opportunities in new and existing markets, demand for licensing of data within the energy industry, operational challenges, and reliance on a cyclical industry and principal customers. Actual results may differ materially from those expected or projected in the forward-looking statements. TGS undertakes no responsibility or obligation to update or alter forward-looking statements for any reason.
For more information, visit TGS.com or contact:
Sven Børre Larsen
Chief Financial Officer
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Innovative Producer, Filmmaker and Author Mick Ebeling to Join Duck Creek’s Formation ’23 as Keynote Speaker27.3.2023 14:30:00 CEST | Press release
Ebeling will discuss pushing the bar and making the inconceivable, the unbelievable and the impossible, not impossible Boston, March 27, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, welcomes Mick Ebeling as its Formation ’23 keynote speaker. Formation, Duck Creek’s annual user conference, attracts the world’s leading insurance industry and technology minds and takes place in Orlando, FL, May 8-10, 2023. Ebeling is the founder and CEO of Not Impossible, a critically acclaimed, award-winning social lab and production company that taps into the power of technology and story to change the world. Formation '23 will empower the P&C and general insurance community with the insights, technology, and inspiration to build better human experiences. As the industry comes together to collaborate and reimage the future of P&C technology, the conference’s theme, “building together,” is me
NGS Group AB: Kallelse till årsstämma i NGS Group AB (publ)27.3.2023 14:15:00 CEST | Pressemelding
Aktieägarna i NGS Group AB (publ), org. nr 556535-1128 ("Bolaget") kallas härmed till årsstämma torsdagen den 27 april 2023, kl. 15.00 i Bolagets lokaler på Kungsgatan 12 i Stockholm. Inregistrering till stämman påbörjas klockan 14:30. Rätt att delta på bolagsstämman Aktieägare som vill delta på bolagsstämman ska: dels vara införd i den av Euroclear Sweden AB förda aktieboken avseende förhållandena per avstämningsdagen onsdagen den 19 april 2023,dels anmäla sig för deltagande på bolagsstämman till Bolaget under adress NGS Group AB (publ), Thomas Plate, Kungsgatan 12, 111 35 Stockholm, per telefon 0768-949 239 eller via e-post till email@example.com. Anmälan ska vara Bolaget tillhanda senast fredagen den 21 april 2023. Vid anmälan ska uppges namn, person- eller organisationsnummer (eller motsvarande), e‑postadress eller telefonnummer dagtid, samt antal aktier och eventuella biträden. Förvaltarregistrerade aktier För att ha rätt att delta i stämman måste en aktieägare som låtit förvaltarr
Transactions in connection with share buyback programme27.3.2023 14:07:42 CEST | Press release
On 8 February 2023, Pandora announced a new share buyback programme, cf. Company announcement no. 769. The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation). The purpose of the programme is to reduce Pandora’s share capital and to meet obligations arising from company incentive programmes. Under the programme Pandora will repurchase shares for an aggregate maximum amount of DKK 2.4 billion with an intention to go up to a total of DKK 5.0 billion during the next 12 months, depending on how the macroeconomic climate develops throughout the year. The programme commenced on 8 February 2023, cf. Company Announcement no. 769, and will conclude no later than 2 February 2024. The following transactions have been made under the programme: Number of sharesAverage purchase price, DKKTransaction value, DKKAccumulated under the programme1,180,000760,396,825 20 Ma
Zoom announces the expansion of Zoom IQ, the smart companion that empowers collaboration and unlocks potential27.3.2023 14:01:10 CEST | Press release
Zoom uses OpenAI technologies to bolster a unique federated approach to AI based on flexibility SAN JOSE, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Today at Enterprise Connect, Zoom Video Communications, Inc. (NASDAQ: ZM) announced the expansion of Zoom IQ, a smart companion that empowers collaboration and unlocks people’s potential by summarizing chat threads, organizing ideas, drafting content for chats, emails, and whiteboard sessions, creating meeting agendas, and more. The company also announced it will use OpenAI to bolster its unique federated approach to AI based on flexibility. Zoom’s federated approach to AI leverages its own proprietary AI models, those from leading AI companies– such as OpenAI –and select customers’ own models. With this flexibility to incorporate multiple types of models, Zoom’s goal is to provide the most value for its customers' diverse needs. These models can also be customized to perform better for a customer, based on their vocabulary and requirement
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences27.3.2023 14:00:00 CEST | Press release
BOSTON and LONDON, March 27, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim Genomic Medicines and Rare Disease Days Date: Monday, April 3, 2023 Location: New York, NY Fireside Chat: 9:35 AM ET Event: Jefferies & Venrock Boston Biotech Summit Date: Wednesday, April 12, 2023 Where applicable, the presentation slides and/or a link to the live webcast of the event, as well as an archived recording, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations. About Centessa Pharmaceuticals Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medi